Cri du chat (CdC) syndrome is a rare genetic disorder caused by a partial deletion of the short arm of chromosome 5. This disorder is named after the characteristic cat-like cry of affected infants. CdC syndrome is a complex disorder with a wide range of physical, cognitive, and behavioral problems. It is estimated to occur in 1 in 50,000 live births worldwide. Although CdC syndrome can be difficult to diagnose, early diagnosis and intervention can help improve the quality of life of individuals with this disorder. This article provides an overview of CdC syndrome, including its causes, symptoms, diagnosis, and management. It also offers guidance to parents on how to best support their child with CdC syndrome.
Cri du chat syndrome is caused by a partial deletion of the short arm of chromosome 5. This deletion occurs randomly during the formation of reproductive cells or during early fetal development. The severity of the deletion determines the severity of the symptoms. In some cases, the deletion is so small that it does not cause any symptoms. The exact cause of the deletion is unknown. However, it is thought to be due to a combination of genetic and environmental factors. For example, some studies have suggested that certain medications taken during pregnancy may increase the risk of CdC syndrome.
The symptoms of CdC syndrome vary depending on the severity of the deletion. Common symptoms include a high-pitched cry that resembles that of a cat, low birth weight, developmental delays, and distinctive facial features. Other symptoms may include microcephaly (small head size), heart defects, hearing loss, vision problems, and feeding difficulties.
CdC syndrome is usually diagnosed through a combination of physical examination, family history, and genetic testing. A physical exam may reveal the characteristic facial features and other physical abnormalities associated with CdC syndrome. A detailed family history may help identify other family members with similar features. Genetic testing is the most reliable method for diagnosing CdC syndrome. It involves analyzing a sample of the patient’s DNA to look for the deletion on chromosome 5. If the deletion is found, a diagnosis of CdC syndrome can be made.
The management of CdC syndrome is aimed at helping the individual reach their full potential. Treatment typically involves a multidisciplinary team of healthcare professionals, including doctors, nurses, psychologists, and occupational therapists. Treatment may include physical, occupational, and speech therapy, medications to control seizures and other symptoms, and psychological support.
Caring for a child with CdC syndrome can be challenging. Parents should be aware that their child may have significant physical, cognitive, and behavioral difficulties. It is important to provide a supportive environment and to understand the individual needs of the child. Parents can also seek out support from other families who have a child with CdC syndrome. Support groups can provide a valuable source of information and emotional support.
Cri du chat syndrome is a rare genetic disorder that can cause a wide range of physical, cognitive, and behavioral difficulties. Early diagnosis and intervention can help improve the quality of life of individuals with this disorder. Parents of children with CdC syndrome should be aware of the challenges they may face and seek out support from other families and healthcare professionals. With the right support, children with CdC syndrome can reach their full potential.
1.
A study outlines the need for policies that enhance cancer patients' autonomy and information.
2.
New CAR T-Cell Therapy Approved for Leukemia
3.
The FDA has approved momelotinib for use in myelofibrosis patients who also have anemia.
4.
The prognosis of the Slovakian PM; Kate Middleton's treatment; and drug test cheating.
5.
Alone for 500 Days, but Never Lonely: The Introvert's Dream.
1.
Precision Oncology: Personalized Medicine Shaping the Future of Cancer Care
2.
Malignant Prolactinoma: Prolactin Surge with Minimal Growth Masks Widespread Metastases
3.
Navigating the Evolving Landscape of Oncology Clinical Trials in the Era of Precision Medicine
4.
CENP-H in Cancer: A Key Player in Tumor Progression and a Potential Therapeutic Target
5.
Understanding Adenomyosis: The Role of Ultrasound in Diagnosis Introduction
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective
2.
Thromboprophylaxis In Medical Settings
3.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part I
4.
Cost Burden/ Burden of Hospitalization For R/R ALL Patients
5.
Breaking Down PALOMA-2: How CDK4/6 Inhibitors Redefined Treatment for HR+/HER2- Metastatic Breast Cancer
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation